Literature DB >> 8693436

Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms.

R Djukanović1, I Feather, C Gratziou, A Walls, D Peroni, P Bradding, M Judd, P H Howarth, S T Holgate.   

Abstract

BACKGROUND: Bronchial challenge with allergen causes a specific form of airways inflammation consisting of an influx of neutrophils, eosinophils, and T cells. Because the relevance of the challenge model to clinical asthma is uncertain, the cellular changes that occur in the lungs of asthmatic subjects during natural seasonal allergen exposure were investigated.
METHODS: Seventeen grass pollen sensitive asthmatic subjects with previously reported seasonal exacerbations of asthma kept records of symptoms and underwent fibreoptic bronchoscopy with bronchoalveolar lavage (BAL) and endobronchial biopsy before and during the peak of the grass pollen season. The BAL cells were analysed for differential cell counts and by flow cytometry for T cell subsets and surface activation markers. The biopsy samples were processed into glycol methacrylate resin and immunohistochemical analysis was performed for mast cells, activated eosinophils, T cells and interleukin 4 (IL-4), a cytokine with a pivotal role in allergen-induced inflammation.
RESULTS: In the pollen season there was an increase in T lymphocyte activation in the BAL fluid as identified by increased expression of interleukin 2 receptor (IL-2R). In the submucosa these changes were paralleled by an increase in CD4+ T cells. By contrast, the numbers of metachromatic cells in BAL fluid staining with toluidine blue were reduced, possibly because of degranulation following allergen stimulation. In keeping with mast cell activation, the number of mucosal mast cells staining for secreted IL-4 increased during the season. In comparison with the period shortly before the onset of the season, all but two subjects experienced an asthma exacerbation which followed the rise in pollen counts but, compared with the period preceding the first bronchoscopic examination, asthma symptoms were not increased during the pollen season.
CONCLUSIONS: The data suggest that natural allergen exposure, leading to a clinical exacerbation of asthma, may induce an inflammatory response involving T cells, mast cells and eosinophils. The relationship between allergen exposure, cellular infiltration and activation, and clinical symptoms appears to be complex, with factors other than allergen also contributing to asthmatic activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8693436      PMCID: PMC1090485          DOI: 10.1136/thx.51.6.575

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  34 in total

1.  Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics.

Authors:  A A Gerblich; H Salik; M R Schuyler
Journal:  Am Rev Respir Dis       Date:  1991-03

2.  Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions.

Authors:  P Diaz; M C Gonzalez; F R Galleguillos; P Ancic; O Cromwell; D Shepherd; S R Durham; G J Gleich; A B Kay
Journal:  Am Rev Respir Dis       Date:  1989-06

3.  IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants.

Authors:  G Del Prete; E Maggi; P Parronchi; I Chrétien; A Tiri; D Macchia; M Ricci; J Banchereau; J De Vries; S Romagnani
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

4.  The cellular response of the human allergic mucosa to natural allergen exposure.

Authors:  U Pipkorn; G Karlsson; L Enerback
Journal:  J Allergy Clin Immunol       Date:  1988-12       Impact factor: 10.793

5.  Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in late-phase responders.

Authors:  M C Gonzalez; P Diaz; F R Galleguillos; P Ancic; O Cromwell; A B Kay
Journal:  Am Rev Respir Dis       Date:  1987-09

6.  Modification of bronchial hyperreactivity during pollen season in children allergic to grass.

Authors:  A Barbato; F Pisetta; A Ragusa; G Marcer; F Zacchello
Journal:  Ann Allergy       Date:  1987-02

7.  Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.

Authors:  R Djukanović; J W Wilson; K M Britten; S J Wilson; A F Walls; W R Roche; P H Howarth; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1990-10

8.  Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase.

Authors:  A F Walls; D B Jones; J H Williams; M K Church; S T Holgate
Journal:  J Pathol       Date:  1990-10       Impact factor: 7.996

9.  Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.

Authors:  M H Thornhill; S M Wellicome; D L Mahiouz; J S Lanchbury; U Kyan-Aung; D O Haskard
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

10.  The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man.

Authors:  A J Frew; A B Kay
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

View more
  14 in total

Review 1.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

2.  Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen.

Authors:  I J Helenius; H O Tikkanen; T Haahtela
Journal:  Br J Sports Med       Date:  1998-06       Impact factor: 13.800

Review 3.  Measurement of airway hyperresponsiveness: new considerations.

Authors:  J Lötvall; M Inman; P O'Byrne
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

Review 4.  Investigative bronchoprovocation and bronchoscopy in airway diseases.

Authors:  William W Busse; Adam Wanner; Kenneth Adams; Herbert Y Reynolds; Mario Castro; Badrul Chowdhury; Monica Kraft; Robert J Levine; Stephen P Peters; Eugene J Sullivan
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

5.  Longitudinal study of grass pollen exposure, symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma.

Authors:  G Roberts; C Hurley; A Bush; G Lack
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

6.  Skin test reactivity to indoor allergens correlates with asthma severity in jeddah, saudi arabia.

Authors:  Emad A Koshak
Journal:  Allergy Asthma Clin Immunol       Date:  2006-03-15       Impact factor: 3.406

7.  Eosinophilic airway inflammation and airway hyperresponsiveness according to aeroallergen sensitization pattern in patients with lower airway symptoms.

Authors:  Eun-Jung Jo; Mi-Yeong Kim; Seung-Eun Lee; Suh-Young Lee; Min-Hye Kim; Woo-Jung Song; Sae-Hoon Kim; Hye-Ryun Kang; Yoon-Seok Chang; Sang-Heon Cho; Kyung-Up Min
Journal:  Allergy Asthma Immunol Res       Date:  2013-10-30       Impact factor: 5.764

8.  Pollen Season Trends (1973-2013) in Stockholm Area, Sweden.

Authors:  Tomas Lind; Agneta Ekebom; Kerstin Alm Kübler; Pia Östensson; Tom Bellander; Mare Lõhmus
Journal:  PLoS One       Date:  2016-11-29       Impact factor: 3.240

9.  Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge.

Authors:  Johannes Schulze; Sandra Voss; Ulrich Zissler; Markus A Rose; Stefan Zielen; Ralf Schubert
Journal:  Respir Res       Date:  2012-09-19

10.  Relationship between atopy and bronchial hyperresponsiveness.

Authors:  Dong In Suh; Young Yull Koh
Journal:  Allergy Asthma Immunol Res       Date:  2013-02-27       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.